BioCentury | Mar 8, 2019
Financial News

MacuLogix raises $38.7M series D

MacuLogix raised $38.7 million in a series D round. New investor Vivo Capital led the round, with participation from existing investors Fisk Ventures, Roche Venture Fund, Berwind Private Equity and Life Sciences Greenhouse of Central...
BioCentury | Apr 7, 2017
Finance

Taking notice

Political overhang during the first quarter kept generalists on the sidelines but provided a buying opportunity for life sciences specialists that led the sector to outperform. With “repeal and replace” in the rearview for now...
BioCentury | May 17, 2010
Finance

Venture Tracks

Bruno Montanari joined Crédit Agricole Private Equity as life sciences investment manager. He was a principal with Atlas Venture. Crédit Agricole has E430 million ($549 million) under management. -- Stacy Lawrence...
BioCentury | Mar 24, 2008
Finance

Nomura's investments

Nomura's investments Nomura's investments Nomura Phase4 Ventures has invested in at least 25 biotechs since 1999. Usually Nomura's contribution for an initial investment will be some $15-$25 million of the round, although in subsequent rounds...
BioCentury | Jul 14, 2003
Finance

Ebb & Flow

...Co., Foundation Medical Partners, Wheatley Partners, MDS Capital Corp. of Canada, The Cleveland Clinic Foundation, equity4Life...
BioCentury | Jul 10, 2003
Financial News

Immunicon raises $24.8 million

...& Co.; Foundation Medical Partners; Wheatley Partners; MDS Capital of Canada; the Cleveland Clinic Foundation; equity4Life...
BioCentury | Jun 10, 2002
Finance

Ebb & Flow

The biotech industry raised a record amount of money in the first quarter, $5.7 billion, the best start to any year for the industry with the exception of 2000, when biotech took in $13.1 billion...
BioCentury | Feb 4, 2002
Finance

Ebb & Flow

...diagnostic developer Immunicon, in a round led by Burrill & Co., joined by Wheatley Partners; equity4Life...
BioCentury | Jan 30, 2002
Financial News

Immunicon raises $28.8 million

...Penn.) raised $28.8 million in a private round. Investors included Burrill & Co.; Wheatley Partners; equity4Life...
BioCentury | Jan 28, 2002
Finance

Ebb & Flow

...of 5,087 new shares. Its third financing round was led by HBM BioVentures and included Equity4Life...
Items per page:
1 - 10 of 19
BioCentury | Mar 8, 2019
Financial News

MacuLogix raises $38.7M series D

MacuLogix raised $38.7 million in a series D round. New investor Vivo Capital led the round, with participation from existing investors Fisk Ventures, Roche Venture Fund, Berwind Private Equity and Life Sciences Greenhouse of Central...
BioCentury | Apr 7, 2017
Finance

Taking notice

Political overhang during the first quarter kept generalists on the sidelines but provided a buying opportunity for life sciences specialists that led the sector to outperform. With “repeal and replace” in the rearview for now...
BioCentury | May 17, 2010
Finance

Venture Tracks

Bruno Montanari joined Crédit Agricole Private Equity as life sciences investment manager. He was a principal with Atlas Venture. Crédit Agricole has E430 million ($549 million) under management. -- Stacy Lawrence...
BioCentury | Mar 24, 2008
Finance

Nomura's investments

Nomura's investments Nomura's investments Nomura Phase4 Ventures has invested in at least 25 biotechs since 1999. Usually Nomura's contribution for an initial investment will be some $15-$25 million of the round, although in subsequent rounds...
BioCentury | Jul 14, 2003
Finance

Ebb & Flow

...Co., Foundation Medical Partners, Wheatley Partners, MDS Capital Corp. of Canada, The Cleveland Clinic Foundation, equity4Life...
BioCentury | Jul 10, 2003
Financial News

Immunicon raises $24.8 million

...& Co.; Foundation Medical Partners; Wheatley Partners; MDS Capital of Canada; the Cleveland Clinic Foundation; equity4Life...
BioCentury | Jun 10, 2002
Finance

Ebb & Flow

The biotech industry raised a record amount of money in the first quarter, $5.7 billion, the best start to any year for the industry with the exception of 2000, when biotech took in $13.1 billion...
BioCentury | Feb 4, 2002
Finance

Ebb & Flow

...diagnostic developer Immunicon, in a round led by Burrill & Co., joined by Wheatley Partners; equity4Life...
BioCentury | Jan 30, 2002
Financial News

Immunicon raises $28.8 million

...Penn.) raised $28.8 million in a private round. Investors included Burrill & Co.; Wheatley Partners; equity4Life...
BioCentury | Jan 28, 2002
Finance

Ebb & Flow

...of 5,087 new shares. Its third financing round was led by HBM BioVentures and included Equity4Life...
Items per page:
1 - 10 of 19